Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
Zoë YGJ van Lierop(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam Neuroscience), Eva Strijbis(Amsterdam Neuroscience), Sam N Hof(Amsterdam UMC Location University of Amsterdam), Zoé L. E. van Kempen(Vrije Universiteit Amsterdam), Liselore A. Mensing(Spaarne Gasthuis), Bastiaan Moraal(Amsterdam UMC Location Vrije Universiteit Amsterdam), Bob W. van Oosten(Amsterdam Neuroscience), Brigit A. de Jong(Amsterdam Neuroscience), Laura Hogenboom(Amsterdam Neuroscience), Nik Sol(Harvard University), Myrthe Willems(Diakonessenhuis hospital), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mark HJ Wessels, Lisa Vermunt(Amsterdam Neuroscience), Womei ML Lekranty(Amsterdam Neuroscience), Nandi Meijs(Zuyderland Medisch Centrum)
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k